Catalyst Wire Dossier Catalyst Wire Dossier

GIMOTI

metoclopramide hydrochloride · Evoke Pharma, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GIMOTI, covering 2020-06-19 to 2026-02-09. Get the full timeline:

Most recent: FDA Approved: GIMOTI — Supplemental Application (Evoke Pharma, Inc.)

See pricing